Category: Drug delivery systems

Intranasal drug administration is a method where medication is delivered through the nasal passages for absorption into the bloodstream. While the question 'What sedative goes up your nose?' might arise in various contexts, this route is primarily utilized in controlled medical settings for specific therapeutic benefits.

An estimated 17.7 million adults in the U.S. have asthma, a condition often treated with a drug mist. A **drug mist** is not a specific medication, but rather a descriptive term for a drug delivery method that turns liquid or powdered medicine into a fine spray or aerosol, which can be easily inhaled or absorbed through nasal passages. This innovative approach is used to treat a wide array of respiratory and other systemic conditions by delivering medication directly to the target site.

With an estimated 76 million people affected worldwide, innovation in glaucoma treatment is crucial to prevent vision loss. For patients and clinicians seeking the latest options, a key question is: what is the newest drug for glaucoma? The answer lies not only in new eye drops but in advanced, sustained-release delivery systems like the iDose TR implant.

According to Scientific American, microneedle technology was named one of the “Top 10 Emerging Technologies that Could Change the World” in 2020 due to its potential for painless injections and improved patient care. This advanced drug delivery method is a key example of what is often meant by a **3D injection** in modern pharmacology: the use of three-dimensional fabrication techniques to create intricate, customized devices for targeted and efficient medication delivery. This is distinct from a non-steroidal anti-inflammatory drug (NSAID) medication also sometimes referred to as '3D Injection', which is simply a brand name for a common injectable drug like diclofenac.

The first commercially available transdermal patch, delivering scopolamine for motion sickness, was approved in 1979. Today, the technology is widespread, and when considering what are the two most common drugs given transdermal, the answers are nicotine and fentanyl, serving vastly different but critical medical needs.

According to the Food and Drug Administration (FDA), the two primary types of time-release medications are delayed-release and extended-release. This special technology controls the drug's delivery, ensuring the active ingredients are released into the body gradually over a specific duration, unlike conventional immediate-release versions.